Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-14

Clinical Trial Update: Pregabalin Treatment and Prevention Post-herpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for pregabalin in postherpetic neuralgia; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Herpetic Neuralgia | Phase 3 | Status: UNKNOWN